AI Uncovers New Potential Treatments for Leigh Syndrome

Researchers from Düsseldorf and Luxembourg used deep learning and human brain organoids to identify new treatment options for Leigh Syndrome ^[1][2]. The study highlighted talarozole and sertaconazole as promising candidates for treating this rare mitochondrial disorder ^[1][3]. These findings aim to address a fatal condition that currently lacks effective therapies ^[2].

The research team applied an AI-driven approach to screen existing drugs for repurposing ^[1]. By using organoids—miniature brain models grown from cells—scientists could observe how these drugs interact with human tissues ^[2][3]. This method significantly reduced the time usually required for traditional drug discovery ^[1].